|Articles|December 1, 1997

December 1997
Volume 3
Issue 12

Adverse Drug Reactions: A Review for Healthcare Practitioners

Author(s)Linda R. Young, PharmD, J. Douglas Wurtzbacher, PharmD, Crystal S. Blankenship, PharmD

Download PDF: Adverse Drug Reactions: A Review for Healthcare Practitioners

Articles in this issue

almost 29 years ago

Article

Cost Implications of Selective Preoperative Screening in the Care of Candidates for Peripheral Vascular Operations

almost 29 years ago

Article

Disease Management Interventions to Improve Outcomes in Congestive Heart Failure

almost 29 years ago

Article

Sedating Effects of AM/PM Antihistamine Dosing with Evening Chlorpheniramine and Morning Terfenadine

almost 29 years ago

Article

Physicians in Training as Quality Managers: Survival Strategy for Academic Health Centers

almost 29 years ago

Article

Gastrointestinal Illness in Managed Care: Healthcare Utilization and Costs

almost 29 years ago

Article

Recognition and Treatment of Patients in the Persistent Vegetative State

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Doctor talking with patient | Image credit: Prostock-studio - stock.adobe.com

Teach-Back Is Essential Care Infrastructure: A Low-Cost Strategy for Safer, More Equitable Care

ByAayush Sisodia, MSHI, BDS

September 15th 2026

Man with chest pain | Image credit: Liubomir - stock.adobe.com

The Right Care Initiative: Promoting Accountable Care to Prevent Cardiovascular Death

ByHector P. Rodriguez, PhD, MPH, Hattie R. Hanley, MPP,Stephen M. Shortell, PhD, MBA, MPH

September 15th 2026

Pregnant woman | Image credit: pressmaster - stock.adobe.com

Early Signs of Success for Missouri’s New Notification of Pregnancy

ByAbigail R. Barker, PhD,Nadim Kanafani, MD,Kelley M. Peters, MS, RN, BSN,Rashmi Srivastava, MD, BS

September 15th 2026

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

Adverse Drug Reactions: A Review for Healthcare Practitioners

Articles in this issue

Related Content

Teach-Back Is Essential Care Infrastructure: A Low-Cost Strategy for Safer, More Equitable Care

The Right Care Initiative: Promoting Accountable Care to Prevent Cardiovascular Death

Early Signs of Success for Missouri’s New Notification of Pregnancy

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Trending on AJMC

FDA Clears First Alzheimer Blood Test for Adults as Young as 40

5 Things to Know About the 2026 ESC Heart Failure Guidelines

FDA Shortens Tarlatamab Monitoring, Widens Access to SCLC Care

Tozorakimab Benefits Current and Former Smokers: Frank Sciurba, MD

RSV Vaccine Shows 100% Effectiveness in COPD: Jorgen Vestbo, MD